Why is serum cortisol measured in myxedema coma, and is intravenous hydrocortisone always required before intravenous levothyroxine to prevent precipitating adrenal crisis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Why Cortisol is Checked and Hydrocortisone Given Before Levothyroxine in Myxedema Coma

Cortisol levels are checked in myxedema coma to identify concurrent adrenal insufficiency, and IV hydrocortisone must always be given before or simultaneously with IV levothyroxine because thyroid hormone replacement increases cortisol metabolism and can precipitate fatal adrenal crisis in patients with unrecognized adrenal insufficiency.

The Critical Rationale

Why Cortisol is Measured

Cortisol levels are checked because:

  • Central hypothyroidism may coexist with adrenal insufficiency in patients with hypopituitarism, where both TSH and ACTH deficiency occur together 1
  • Primary hypothyroidism can occur alongside primary adrenal insufficiency (Addison's disease) in autoimmune polyglandular syndromes 2
  • The clinical presentation overlaps significantly - both conditions cause altered mental status, hypotension, hyponatremia, and cardiovascular instability, making it impossible to distinguish them clinically in myxedema coma 3, 4
  • Adrenal crisis has 8.3 events per 100 patient-years in those with known adrenal insufficiency, with mortality occurring even with treatment 5

Why Hydrocortisone Must Come First

The FDA drug label for levothyroxine explicitly contraindicates its use in uncorrected adrenal insufficiency 6. This is not a theoretical concern but a life-threatening risk:

  • Thyroid hormone increases metabolic clearance of glucocorticoids 6, meaning levothyroxine administration will rapidly deplete whatever cortisol reserves exist
  • This precipitates acute adrenal crisis characterized by cardiovascular collapse, refractory hypotension, and death 7, 6
  • The risk exists even if cortisol levels appear "normal" because stress-appropriate cortisol levels (which should be elevated in critical illness) may actually represent relative adrenal insufficiency 5

The Clinical Algorithm

When Myxedema Coma is Suspected:

  1. Draw baseline labs immediately (cortisol, ACTH, TSH, free T4) but do not wait for results 2

  2. Administer IV hydrocortisone 100 mg bolus immediately 2, 8, 2, 7

    • Follow with continuous infusion of 200 mg/24 hours OR
    • Give 50-100 mg IV/IM every 6 hours 2, 7
  3. Only after hydrocortisone is on board, give IV levothyroxine loading dose 1, 3, 4

  4. Continue hydrocortisone for at least 24-48 hours before tapering, regardless of initial cortisol results 2, 8, 2

Is This ALWAYS Necessary?

Yes, in myxedema coma, hydrocortisone should always be given before levothyroxine 1. The guideline evidence is unequivocal:

  • The 2021 ASCO guideline states: "If there is uncertainty about whether primary or central hypothyroidism is present, hydrocortisone should be given before thyroid hormone is initiated" 1
  • Multiple consensus statements recommend empiric hydrocortisone in myxedema coma even without confirmed adrenal insufficiency 2, 8, 2, 7
  • Case reports document fatal outcomes when this principle is violated 3, 4

Key Clinical Pitfalls

Common Mistakes to Avoid:

  • Don't wait for cortisol results - treatment delays increase mortality 2
  • Don't assume normal baseline cortisol excludes adrenal insufficiency - stress should elevate cortisol significantly; "normal" levels in critical illness suggest inadequate reserve 5
  • Don't use dexamethasone alone - it lacks mineralocorticoid activity and can precipitate crisis in primary adrenal insufficiency 7
  • Don't stop hydrocortisone too early - continue stress dosing until the patient is clinically stable and recovering 2, 8, 2

Special Considerations:

  • In central hypothyroidism (low TSH, low T4), the risk of concurrent ACTH deficiency is particularly high, making hydrocortisone absolutely mandatory 1
  • Mineralocorticoid replacement (fludrocortisone) is not needed acutely because high-dose hydrocortisone (≥100 mg) provides sufficient mineralocorticoid activity 2, 7
  • Once hydrocortisone dose drops below 50 mg/day, restart fludrocortisone 0.05-0.1 mg daily in primary adrenal insufficiency 2, 8

The Evidence Hierarchy

The strongest evidence comes from:

  • FDA drug labeling explicitly contraindicating levothyroxine in uncorrected adrenal insufficiency 6
  • 2021 ASCO guidelines providing clear algorithmic management 1
  • 2020 UK consensus guidelines on perioperative glucocorticoid management demonstrating the mortality risk of adrenal crisis 5
  • Multiple endocrine society consensus statements uniformly recommending empiric hydrocortisone 2, 8, 2, 7

The mortality from untreated adrenal crisis (up to 60% in myxedema coma) far exceeds any risk from empiric hydrocortisone administration 9, 10. This makes the decision straightforward: always give hydrocortisone first.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.